Resumen
We describe the development of a novel, high-throughput, nano-scale microarray platform for antimicrobial susceptibility testing (AST). The platform allows to process 480 samples at 50 nL volume on a single chip, analyze by fluorescence read-out with an easy dunk-and-rinse step, and the ability to process multiple samples and chips simultaneously. We demonstrate the applicability of this chip for culturing community acquired methicillin resistant Staphylococcus aureus (CA-MRSA), and perform AST against clinical isolates of CA-MRSA. The chip platform holds promise for an impact in microbial biotechnology as an attractive high-throughput, lower sample volume and quicker alternative to conventional AST such as the traditional broth microdilution or the newer automated systems.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 44-47 |
| Número de páginas | 4 |
| Publicación | Biotechnology Reports |
| Volumen | 16 |
| DOI | |
| Estado | Published - dic 2017 |
ASJC Scopus subject areas
- Biotechnology
- Applied Microbiology and Biotechnology
Huella
Profundice en los temas de investigación de 'High-throughput microarray for antimicrobial susceptibility testing'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS